{"id":765,"date":"2022-04-21T14:02:55","date_gmt":"2022-04-21T05:02:55","guid":{"rendered":"http:\/\/vocs-medical.co.jp\/?page_id=765"},"modified":"2022-07-06T16:55:55","modified_gmt":"2022-07-06T07:55:55","slug":"company","status":"publish","type":"page","link":"https:\/\/www.vocs-medical.co.jp\/en\/company\/","title":{"rendered":"COMPANY"},"content":{"rendered":"

[vc_row][vc_column]

\n \n
\n
\n
\n

About Us<\/h1>\n

<\/h5>\n <\/div>\n <\/div>\n\n <\/div>\n \n\n <\/section>\n[\/vc_column][\/vc_row][vc_row ses_title=”MESSAGE” type_row=”services”][vc_column width=”1\/6″ type=”column”][\/vc_column][vc_column width=”2\/3″ type=”column”][vc_column_text css_animation=”fadeIn”]<\/p>\n

The spread of DX, including IOT, through the improvement of digital technology has brought convenience and rapid changes to our living environment.The daily life that has been based on labor time as the price is now no longer worth it. Instead, “Simplicity” \u2013 \u201cPrecision” – “Speed” are pursued for all services that people come in contact with.<\/span><\/p>\n

The digitalization of medical care, which originated in the U.S., has spurred rapid development competition, transcended corporate boundaries, conducted an engineering-based verification of all aspects of medical care, and created E-Medical. <\/span><\/p>\n

We have continued research and development of “disease testing technology by exhaled breath” in various approaches with specialized teams in each fields.<\/span>We have completed clinical trials in Israel, the U.S., and Japan, and have reached the phase of getting FDA approval for medical care device as an in vitro diagnostic product in Japan and other Asian countries.<\/span><\/p>\n

While surgical and pharmacological treatments for various pathologies are evolving day by day and multidisciplinary treatment is nowadays being provided, our mission is to realize “early pathology detection” for all diseases that affect humans.VOCs System enables a new testing method to detect early pathology that is easy, painless, and time- and location-independent for more people.<\/span><\/p>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/6″][\/vc_column][\/vc_row][vc_row type_row=”about”][vc_column width=”1\/3″ type=”column”] \n

CONCEPT<\/h4>\n

Breast cancer is said to affect one in nine Japanese women.Mammography, a major medical examination for breast cancer, is often avoided because of the exposure to radiation and severe pain.
\nOn the other hand, tumors detected at an Early Stage have a survival rate of over 95% and are curable.
\n``Easier and Painless`` breast cancer screening<\/p>\n

<\/p>\n\n

<\/a><\/p>\n [\/vc_column][vc_column width=”1\/3″ type=”column” el_class=”line_white”][vc_custom_heading text=”Approximate numbers in breast cancer (%)” font_container=”tag:h5|text_align:left” google_fonts=”font_family:Noto%20Sans%3Aregular%2Citalic%2C700%2C700italic|font_style:400%20regular%3A400%3Anormal”][vc_custom_heading text=”Incidence rate among Japanese females” font_container=”tag:h6|text_align:left” google_fonts=”font_family:Noto%20Sans%3Aregular%2Citalic%2C700%2C700italic|font_style:400%20regular%3A400%3Anormal”] \n

-<\/h6>\n
\n
\n <\/span>\n <\/div>\n <\/div>\n [vc_custom_heading text=”Breast cancer screening uptake rate” font_container=”tag:h6|text_align:left” google_fonts=”font_family:Noto%20Sans%3Aregular%2Citalic%2C700%2C700italic|font_style:400%20regular%3A400%3Anormal”] \n
-<\/h6>\n
\n
\n <\/span>\n <\/div>\n <\/div>\n [\/vc_column][vc_column width=”1\/3″ type=”column”][vc_custom_heading text=”5-year survival rate by cancer stage (%)” font_container=”tag:h5|text_align:left” google_fonts=”font_family:Noto%20Sans%3Aregular%2Citalic%2C700%2C700italic|font_style:400%20regular%3A400%3Anormal”] \n
Stage I<\/h6>\n
\n
\n <\/span>\n <\/div>\n <\/div>\n \n
Stage III<\/h6>\n
\n
\n <\/span>\n <\/div>\n <\/div>\n \n
Stage IV<\/h6>\n
\n
\n <\/span>\n <\/div>\n <\/div>\n [vc_column_text el_class=”note”]<\/p>\n

*The above figures are approximate.<\/span><\/p>\n

Stage I: 99.8% \/ Stage III,: 80.7% \/ Stage IV: 38.7%<\/span><\/p>\n

[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column][vc_raw_html]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[\/vc_raw_html][\/vc_column][\/vc_row][vc_row type_row=”about”][vc_column width=”1\/4″][\/vc_column][vc_column width=”1\/2″][vc_column_text]<\/p>\n\n\n\n\n\n\n
Company name<\/th>\nVOCs Medical JAPAN Co.<\/td>\n<\/tr>\n
Address<\/th>\nOtemachi First Square East Tower 4F, 1-5-1 Otemachi, Chiyoda-ku, Tokyo<\/td>\n<\/tr>\n
Capital<\/th>\n45,000,000 yen<\/td>\n<\/tr>\n
Business activities<\/th>\nMedical equipment sales business, import\/export of related products, storefront sales business, agency business, medical equipment manufacturing<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

[\/vc_column_text][\/vc_column][vc_column width=”1\/4″][\/vc_column][\/vc_row][vc_row][vc_column]

<\/div><\/section>\n\t